Where does TLC Biopharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), TLC Biopharmaceuticals, Inc. ranks #11,481 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does TLC Biopharmaceuticals, Inc. hold?

TLC Biopharmaceuticals, Inc. holds 27 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is TLC Biopharmaceuticals, Inc.'s Innovation Score?

TLC Biopharmaceuticals, Inc. has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does TLC Biopharmaceuticals, Inc. focus on?

TLC Biopharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 26 patents, ranking #871 of 7,163 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is TLC Biopharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

TLC Biopharmaceuticals, Inc.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for TLC Biopharmaceuticals, Inc.'s patents?

TLC Biopharmaceuticals, Inc.'s patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the TLC Biopharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

TLC Biopharmaceuticals, Inc.

USPTO PatentsView assignee record - 27 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, TLC ranks #11,481 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 6 technology areas.

#11,481
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 15.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11481 · US Corporation #11,481 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,481/49,997
PHOTO-FINISH Think Laboratory
CPC-NARROW A61K · 6 areas
INNOV-THIN 34.1/100
CLAIMS-RICH 15.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Think Laboratory Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How TLC’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (34%) Velocity 4.4 pts (13%) Breadth 8.7 pts (26%) Claim depth 9.5 pts (28%)

Qualcomm Incorporated · highest

85
Baby Jogger · near

34
SCA Tissue France · near

34
Barilla G & R… · near

34
Kyland Technology · near

34
TLC Biopharmaceuticals · this assignee

34
3D Lighting… · lowest

7

What this shows TLC's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for TLC?

Each dot is one of TLC’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). TLC’s own 15.8 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

TLC vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where TLC's grants concentrate

TLC Biopharmaceuticals, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 96.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2015. By volume, TLC sits between Think Laboratory Co., Ltd. and Transgene SA.

TLC's three-year grant acceleration

TLC Biopharmaceuticals, Inc. shows 6 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Think Laboratory

27
THL Holding

27
Tineco Intelligen…

27
Tissuetech

27
Tokyo Electric Po…

27
Toyo Aerosol Indu…

27
Toyo Boseki

27
Transgene

27
TLC Biopharmaceut… ◀

27

What this shows TLC holds 27 patents at rank #11,467, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near TLC

By rank, the assignees closest to #11,467 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in TLC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for TLC, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), TLC ranks #871 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Barilla G. & R. Fratelli S.p.A. 34 Kyland Technology Co., Ltd. 34 SCA Tissue France 34 Baby Jogger, LLC 34

TLC's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

TLC Biopharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.7%
2017	2	7.4%
2018	2	7.4%
2019	5	18.5%
2020	1	3.7%
2021	3	11.1%
2022	1	3.7%
2023	3	11.1%
2024	2	7.4%
2025partial year	7	25.9%

Which technologies does TLC Biopharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 26

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

C07K - Peptides 8

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

TLC Biopharmaceuticals, Inc.'s patent record in context - here's where to go next.

TLC Biopharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #11,481 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare TLC Biopharmaceuticals, Inc. against Think Laboratory Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.